Oxford Genome Sciences and University of Oxford to develop new clinical biomarkers for colorectal cancer
OGeS joins consortium focused on the development of new personalised management of colorectal cancer
13-Apr-2006 -
Oxford Genome Sciences (UK) Ltd (OGeS) announced that it has entered into collaboration with the
Department of Clinical Pharmacology at the University of Oxford to discover new clinical biomarkers for colorectal cancer (CRC).
The collaboration forms part of a consortium, which was initiated in ...
biomarkers
chemotherapy
colorectal cancer
+4